# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001683168-21-000711
Filing Date
2021-02-25
Accepted
2021-02-25 09:00:56
Documents
28
Period of Report
2021-02-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | cns_8k.htm | 8-K | 18956
2 | CNS PHARMACEUTICALS, INC. INVESTOR PRESENTATION - FEBRUARY 2021 | cns_ex9901.htm | EX-99.1 | 45160
3 | GRAPHIC | image_001.jpg | GRAPHIC | 62825
4 | GRAPHIC | image_002.jpg | GRAPHIC | 78625
5 | GRAPHIC | image_003.jpg | GRAPHIC | 84419
6 | GRAPHIC | image_004.jpg | GRAPHIC | 123550
7 | GRAPHIC | image_005.jpg | GRAPHIC | 66819
8 | GRAPHIC | image_006.jpg | GRAPHIC | 102394
9 | GRAPHIC | image_007.jpg | GRAPHIC | 95658
10 | GRAPHIC | image_008.jpg | GRAPHIC | 125098
11 | GRAPHIC | image_009.jpg | GRAPHIC | 105279
12 | GRAPHIC | image_010.jpg | GRAPHIC | 94717
13 | GRAPHIC | image_011.jpg | GRAPHIC | 96914
14 | GRAPHIC | image_012.jpg | GRAPHIC | 111863
15 | GRAPHIC | image_013.jpg | GRAPHIC | 105557
16 | GRAPHIC | image_014.jpg | GRAPHIC | 105969
17 | GRAPHIC | image_015.jpg | GRAPHIC | 120520
18 | GRAPHIC | image_016.jpg | GRAPHIC | 97329
19 | GRAPHIC | image_017.jpg | GRAPHIC | 112414
20 | GRAPHIC | image_018.jpg | GRAPHIC | 121260
21 | GRAPHIC | image_019.jpg | GRAPHIC | 88798
22 | GRAPHIC | image_020.jpg | GRAPHIC | 132822
23 | GRAPHIC | image_021.jpg | GRAPHIC | 74309
24 | GRAPHIC | image_022.jpg | GRAPHIC | 83499
25 | GRAPHIC | image_023.jpg | GRAPHIC | 132548
26 | GRAPHIC | image_024.jpg | GRAPHIC | 103494
27 | GRAPHIC | image_025.jpg | GRAPHIC | 102808
28 | GRAPHIC | image_026.jpg | GRAPHIC | 59851
| Complete submission text file | 0001683168-21-000711.txt |  | 3635029

Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 21676687
SIC: 2834 Pharmaceutical Preparations